An analysis from Dope NM places medical purchases at 21% of statewide cannabis sales in July 2026, compared with 44% in April 2022. The report also examines differences among communities.

Sales share measures dollars in a changing market. By itself, it does not establish changes in patient enrollment or medical need. The original analysis provides the figures and geographic context.